Healthtech Startups
17,197 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
Cue Biopharma is a precision immunotherapy company developing engineered therapies targeting allergic and autoimmune diseases. The company's pipeline includes CUE-221 for IgE-mediated allergic disease and CUE-401 advancing from its proprietary Immuno-STAT platform for autoimmune conditions.
0 investors
0 investors
0 investors
Cura OS provides documentation and session management software for day habilitation and group services programs, designed to streamline data entry for direct support professionals serving clients in community-based day programs.
0 investors
0 investors
Curelab Oncology develops anti-cancer drugs with a focus on gene therapy and immuno-oncology, taking programs from early discovery through clinical development. It is a biotech company operating in the oncology drug development space.
0 investors
CureLab Veterinary develops ElenaVet, a plasmid DNA gene therapy encoding the p62/SQSTM1 protein to reduce chronic inflammation and enhance anticancer immune response in pets, targeting conditions such as breast cancer, melanoma, osteoarthritis and inflammatory bowel disease in dogs, cats and horses. The company works with academic and private veterinary clinics through comparative medicine studies and is a sister company of CureLab Oncology, which focuses on human immuno-oncology.
0 investors
Curemark is a clinical-stage biopharmaceutical company developing therapies for neuro-developmental and neurodegenerative disorders. Its lead candidate, CM-AT, is a disorder-modifying therapy for Autism.
0 investors
0 investors
0 investors
Cypris Medical develops minimally-invasive medical devices and treatments designed specifically for plastic surgeons to deliver results comparable to traditional surgery with shorter recovery times. The company combines medical device expertise with input from practicing surgeons to address unmet needs in the plastic surgery market.
0 investors
Cyprium Therapeutics develops therapies for rare genetic diseases, with a focus on treatments for Menkes disease. The company's pipeline includes ZYCUBO (copper histidinate) and AAV-ATP7A gene therapy candidates.
0 investors
CytoDyn is a biopharmaceutical company conducting clinical trials, including a Phase 2 colorectal cancer trial.
0 investors
Cytonics develops biologic therapies targeting osteoarthritis, with lead candidate CYT-108, a recombinant protease inhibitor for knee joint regeneration based on a novel pathway to restore cartilage-secreting cells. The company funds development through equity crowdfunding from individual investors rather than venture capital.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Daré Bioscience is a female-led biotech company developing treatments for women's health conditions that are overlooked in the healthcare industry. The company uses rigorous clinical trial methods and evidence-based research to bring FDA-approved and pipeline therapeutics to patients through both traditional regulatory pathways and compounding services.
0 investors